Establishing Uttar Pradesh as India’s premier hub for Pharmaceutical and Medical Device excellence through a ₹11,000 Crore investment surge.
Total MoUs Signed – ₹11,000+ Cr
Strategic Agreements – 236
State Economy Target – $1 Trillion
Strategic Vision & Objectives
The conclave marks a pivotal shift in Uttar Pradesh’s economic landscape. Under the leadership of Chief Minister Yogi Adityanath, the state is transforming into a self-reliant manufacturing base.
The initiative addresses India’s reliance on imports, aiming to secure National Health Security by fostering a transparent, investor-friendly environment for industry giants like Sun Pharma, Zydus, and Dr. Reddy’s.
Self-Reliant Manufacturing
Import Substitution
Global Competitiveness
Skilled Job Creation
“Uttar Pradesh is committed to providing a secure and transparent ecosystem for global pharmaceutical leaders.”
— Hon’ble CM Yogi Adityanath
Strategic Infrastructure
World-class facilities designed to house the future of pharmaceutical and medical technology manufacturing.
Major Initiative
Lalitpur Bulk Drug Park
1,472 Acres₹8,000 Cr InvestmentAPI Focus
North India’s first dedicated Bulk Drug Pharma Park. Designed to break the dependence on Chinese API imports by providing centralized effluent treatment, testing laboratories, and dedicated logistics support.
- Common Effluent Treatment (CETP)
- Dedicated Power Grid
- Logistics Hub & Rail Access
- Skill Training Center
Greater Noida Medical Device Park
Strategically located adjacent to the Noida International Airport, this 350-acre hub focuses on high-tech diagnostic equipment and surgical technology.
StatusNearing Completion & Readiness
ConnectivityAirport & Yamuna Expressway Link
Investor-Friendly Policy Framework
The UP Pharma Policy 2023 provides a competitive edge, significantly reducing operational and setup costs for manufacturers.
Policy Highlights
- 15% Capital Subsidy
- 100% Stamp Duty Exemption
- 100% Electricity Duty Waiver
FDI / Fortune 500 Policy
Bespoke incentives for global pharmaceutical giants and Fortune India 500 companies to establish large-scale footprints.
Employment Policy 2022
Focused on industrial growth and streamlining the Ease of Doing Business (EoDB) for all pharma entrepreneurs.
Global Capability Centres
Fostering a high-skill talent pool and innovation culture specifically tailored for R&D and pharmaceutical tech.
Drug Administration (FSDA)
Single-window clearance and simplified regulatory processes for drug approvals and licensing.
Pledging a Visionary Future
Production Capacity
Massive increase in domestic drug and API manufacturing.
Economic Growth
Direct contribution to the state’s $1 trillion GSDP target.
Quality of Life
Improved healthcare access for over 240 million residents.
Historical Moment
Formal signing of ₹11,000 Cr MoUs with 236 global industry leaders.
The Path Ahead: Sustaining Momentum
Skill Development
Ensuring a steady pipeline of professionals through specialized vocational training hubs.
Research & Development
Fostering a startup ecosystem and industry-academia collaborations for innovation.
Regulatory Streamlining
Continuous refinement of approval processes to ensure international standard compliance.
Infrastructure Scaling
Expanding road, power, and water connectivity to keep pace with rapid industry expansion.
Building a Global Pharma Leader
Uttar Pradesh is no longer just a state; it is a global destination for pharmaceutical innovation, economic prosperity, and national health security.
About the Author
